Daniel Loeb
Third Point
Daniel Loeb Cano Health Inc stake
total: 588
Third Point CANO trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2020 Q4
- Held for:
- 8 quarters
- Latest activity:
- 2022 Q4
According to 2026 Q2 report, Daniel Loeb doesn't hold any Cano Health Inc (CANO) shares. To date, the estimated cost basis is nearly $12.47 for "buy" trades and estimated average "sell" price is $9.59. Third Point first purchased CANO in 2020 Q4, initially acquiring about 5.75M shares. Since the initial investment in Cano Health Inc (CANO), Third Point has made 6 more transactions.
When did Daniel Loeb sell Cano Health Inc (CANO)?
Daniel Loeb sold off the entire Cano Health Inc (CANO) position in 2022 Q4.
When did Daniel Loeb buy Cano Health Inc (CANO)?
Daniel Loeb first invested in Cano Health Inc (CANO) in 2020 Q4 at the reported quarter-end price of $13.41 per share.
What's the cost basis of Third Point's CANO stake?
The estimated cost basis for Cano Health Inc (CANO) stake is around $12.47 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $12.47
- Weighted AVG sell price:
- $9.59
Daniel Loeb's historical trades in Cano Health Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$8.67
|
|
-100% (-10,825,000)
|
-1.7%
|
|
2022 Q2
|
1.12%
|
10,825,000
|
$4.38
|
$47,414,000
|
-5.87% (-675,000)
|
-0.04%
|
|
2022 Q1
|
0.95%
|
11,500,000
|
$6.35
|
$73,025,000
|
+1.91% (+215,808)
|
+0.02%
|
|
2021 Q4
|
0.70%
|
11,284,192
|
$8.91
|
$100,542,000
|
+1.80% (+200,000)
|
+0.01%
|
|
2021 Q2
|
0.79%
|
11,084,192
|
$12.10
|
$134,119,000
|
+431.82% (+9,000,000)
|
+0.64%
|
|
2021 Q1
|
0.19%
|
2,084,192
|
$13.25
|
$27,616,000
|
-63.75% (-3,665,808)
|
-0.37%
|
|
2020 Q4
|
0.59%
|
$13.41
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.